Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Michigan Rogel Cancer Center
With
Rush University Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Is the patient 18 years of age or older.
Does the patient have histologically or cytologically proven carcinoma of the pancreas
Is the tumor unresectable or medically inoperable
Does the patient have a Zubrod performance status of ≤ 2 (appendix I).
Does the patient have an absolute neutrophil count of ≥ 1500/mm3, and platelets ≥ 100,000/mm3
Does the patient have adequate renal function (creatinine \< 2 mg/dl) and hepatic function (bilirubin \< 3 mg/dl), with relief of biliary obstruction if present
Is the patient free of significant co-morbid conditions that would preclude safe administration or completion of protocol therapy
If the patient is of reproductive potential, has he or she agreed to use an effective method of contraception during treatment on this trial and for 6 months after treatment
Is the patient aware of the investigational nature of the therapy such that they can provide written informed consent
You may not be if
Does the patient have a neuroendocrine tumor of the pancreas
Does the patient have metastatic disease
Does the patient have a history of abdominal radiation therapy
Is there history of more than 1 month of therapy with single agent gemcitabine
Has the patient used any investigational agent in the month before enrollment into the study
